Category: Our News

Montreal, November 19, 2018 – CQDM, Diazon and the Oncopole, in collaboration with Mitacs, are pleased to announce the creation of the Gordon Shore Prize to pay tribute to the remarkable accomplishments of Professor Shore in the field of cancer research. CQDM, Diazon, the Oncopole, in collaboration with Mitacs, will endow the newly founded Gordon…

Montreal, October 19, 2018 – The sector-based industrial research clusters (RSRI) congratulate the new Minister of the Economy and Innovation, Mr. Pierre Fitzgibbon, and assure him and the entire government of their full and active collaboration to stimulate the link between academic research and innovative businesses in Quebec. Representing Quebec’s flagship sectors, the RSRIs are…

Zoic Capital, Desjardins Capital and Other Investors Join Montréal-based Alzheimer Early Detection Optina Diagnostics $4 M Seed Round Montréal, Québec, Oct. 10, 2018—Optina Diagnostics Inc., a leader in early detection of Alzheimer through the use of Artificial Intelligence (AI) and Spectral Retinal Imaging, has raised C$4 million in a new round of funding to scale…

The 29th Life Sciences Success Conference “Inspiring Success Series: Optel, technologies for a better world” will take place on October 10, 2018. It’s an information session on funding programs in Life Sciences and Health Technologies. CQDM will present these funding programs. You can access conference details by clicking here. LIFE SCIENCES CONFERENCEWEDNESDAY, OCTOBER 10, 2018Optel…

About CQDM CQDM is a not-for-profit pharma-based consortium active in biopharmaceutical research whose mission is to fund the development of innovative tools and technologies to accelerate drug discovery. Unique in the world, CQDM’s business model is based on a collaborative approach where all stakeholders share the costs of biopharmaceutical research and benefit from its results.…

As part of its SynergiQc program and in addition to its regular and ongoing call for proposals, CQDM is pleased to inform the Quebec research community of the launch of a targeted Call for Proposals focused on breast cancer research. Thanks to a partnership established with the Canadian Cancer Society, up to $5M will be…

Every dollar raised in Quebec by the Canadian Cancer Society CIBC Run for the Cure will be matched by CQDM Montreal, June 20, 2018 – The Canadian Cancer Society (CCS), a leader in breast cancer research funding in the province and Quebec’s largest cancer group offering support services to people living with breast cancer, is proud to announce…

BOSTON, JUNE 6, 2018 – CQDM is pleased to announce the funding of a new $1.1 million research project in conjunction with financial contributions from lead industrial partner, Immune Biosolutions, and co-funding from: Cancer Research Society, Mitacs, Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke and TransferTech. The funds will be used by the Université…

BOSTON, June 6, 2018 – CQDM is pleased to announce that Takeda Pharmaceutical Company Limited and Roche have joined the CQDM as new members. Members leverage the consortium’s strength to identify and finance innovative biopharmaceutical research projects from across Canada, with the ultimate goal of enabling the development of better treatments for patients. « Je salue…

QUÉBEC city, March 29, 2018 – CQDM is pleased to announce the selection of a new Quantum Leap project jointly with Feldan Therapeutics for a total amount of $1.2M. The funds will be used for further development of a breakthrough drug delivery technology, in collaboration with Professor Frédéric Calon from Laval University. CQDM’s support for this…